Cargando…
Silencing of Fanconi Anemia Complementation Group F Exhibits Potent Chemosensitization of Mitomycin C Activity in Breast Cancer Cells
PURPOSE: Fanconi anemia complementation group F (FANCF) is a key factor to maintaining the function of Fanconi anaemia/BRCA (FA/BRCA) pathway, a DNA-damage response pathway. However, the functional role of FANCF in breast cancer has not been elucidated. In the present study, we evaluated the chemose...
Autores principales: | Yu, Jiankun, Zhao, Lin, Li, Yanlin, Li, Na, He, Miao, Bai, Xuefeng, Yu, Zhaojin, Zheng, Zhihong, Mi, Xiaoyi, Wang, Enhua, Wei, Minjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Breast Cancer Society
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800725/ https://www.ncbi.nlm.nih.gov/pubmed/24155758 http://dx.doi.org/10.4048/jbc.2013.16.3.291 |
Ejemplares similares
-
The Fanconi anemia pathway sensitizes to DNA alkylating agents by inducing JNK-p53-dependent mitochondrial apoptosis in breast cancer cells
por: Zhao, Lin, et al.
Publicado: (2022) -
Gene Silencing of FANCF Potentiates the Sensitivity to Mitoxantrone through Activation of JNK and p38 Signal Pathways in Breast Cancer Cells
por: Li, Yanlin, et al.
Publicado: (2012) -
Use of the cell division assay to diagnose Fanconi anemia patients' hypersensitivity to mitomycin C
por: Hammarsten, Ola, et al.
Publicado: (2020) -
Evaluation of concentration and storage effects of mitomycin C in the diagnosis of Fanconi anemia among idiopatic aplastic anemia patients
por: Mozdarani, H., et al.
Publicado: (2011) -
Identification of the Fanconi Anemia Complementation Group I Gene, FANCI
por: Dorsman, Josephine C., et al.
Publicado: (2007)